CytoDyn Inc. (CYDY)
SEC fundamentals · as filed in 10-Q FY2026, period ended Aug 31, 2026 · updated Oct 16, 2026
as filed in 10-Q FY2026, period ended Aug 31, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Aug 31, 2026, CytoDyn Inc. reported net income of -$19.9M and total assets of $19.1M. Every figure below is taken directly from CytoDyn Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2026 | — | -$42.7M |
| FY2025 | — | $3.7M |
| FY2024 | — | -$49.8M |
| FY2023 | $0 | -$79.8M |
| FY2022 | $266,000 | -$210.8M |
| FY2021 | $0 | -$176.5M |
| FY2020 | — | -$139.9M |
| FY2019 | — | -$56.2M |
| FY2018 | — | -$50.1M |
| FY2017 | — | -$25.8M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Oct 19, 2026 | on EDGAR ↗ |
| 10-Q | Oct 14, 2026 | on EDGAR ↗ |
| DEF 14A | Sep 28, 2026 | on EDGAR ↗ |
| 10-K | Aug 31, 2026 | on EDGAR ↗ |
| 8-K | Apr 30, 2026 | on EDGAR ↗ |
| S-1 | Apr 22, 2026 | on EDGAR ↗ |
| 10-Q | Apr 8, 2026 | on EDGAR ↗ |
| 8-K | Mar 24, 2026 | on EDGAR ↗ |
| 8-K | Mar 5, 2026 | on EDGAR ↗ |
| 10-Q | Jan 9, 2026 | on EDGAR ↗ |
Balance Sheet
as of Aug 31, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Aug 31, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Aug 31, 2026
| EPS (diluted) | $-0.01 | Earnings | source ↗ |
| EPS (basic) | $-0.01 | Earnings | source ↗ |
| Shares Outstanding | 1.47B | Entity | source ↗ |
| Cash from Operations | -$7.7M | Net | source ↗ |
| Cash from Financing | $12.2M | Net | source ↗ |
| Cash from Investing | $0 | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
No open-market Form 4 transactions filed in the last 180 days.
Restatement history
Point-in-time8 of 376 annual fact-keys were materially restated between filings: what CytoDyn Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches CYDY’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/CYDY
MCP tool:
get_sec_fundamentals ticker=CYDY - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/CYDY/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=CYDY as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/CYDY/history
MCP tool:
get_fundamentals_history ticker=CYDY - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/CYDY
MCP tool:
get_financial_health ticker=CYDY
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.